Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1989-12-15
1991-08-27
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514903, A61K 31225
Patent
active
050433555
ABSTRACT:
The use is disclosed of compounds of general formula ##STR1## wherein: Y is methyl, and
REFERENCES:
patent: 4343816 (1982-08-01), Cavazza
patent: 4346107 (1982-08-01), Cavazza et al.
patent: 4439438 (1984-05-01), Cavazza
patent: 4751242 (1988-06-01), Calvani et al.
Francia; Giorgio, Chem Abstracts 106:32722K (1986).
Benzi; G. et al., Chem Abstracts 98:213670D (1983).
Fariello; R. G. et al., Chem Abstracts 105:127432J (1986).
Chemio Syntex, Chem. Abstracts 107:198929C (1987).
Hollinden Gary E.
Raymond Richard L.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Use of L-carnitine derivatives in the therapeutical treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of L-carnitine derivatives in the therapeutical treatment of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of L-carnitine derivatives in the therapeutical treatment of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1414373